Merry-Jennifer Markham

20PUBLICATIONS
94CO-AUTHORS
Molecular targetsCancer geneticsInformation systems philosophy, research methods and theoryOrganisational, interpersonal and intercultural communicationMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Dec 12, 2025
Phase II Trial of Ribociclib Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube, or Peritoneum: A GOG Partners Trial (GOG 3026).

Brian M Slomovitz, S John Weroha, Wei Deng

|Dec 03, 2024
Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient Neoplasms.

Thomas J George, Ji-Hyun Lee, David L DeRemer

|Aug 21, 2023
The Careers and Professional Well-Being of Women Oncologists During the COVID-19 Pandemic: Responding for Tomorrow.

Shivani Majmudar, Stephanie L Graff, Marah Kays

|Feb 13, 2023
Impact of the Immediate Release of Clinical Information Rules on Health Care Delivery to Patients With Cancer.

P Abena Anyidoho, Claire F Verschraegen, Merry Jennifer Markham

|Jan 10, 2023
Clinician Communication With Patients About Cancer Misinformation: A Qualitative Study.

Carma L Bylund, Michaela D Mullis, Jordan Alpert

|Sep 28, 2022
Comparing Transactional eHealth Literacy of Individuals With Cancer and Surrogate Information Seekers: Mixed Methods Study.

Taylor S Vasquez, Carma L Bylund, Jordan Alpert

Pageof 4

Frequent Collaborators

3 joint publications

Stephanie L Graff

3 joint publications

Carma L Bylund

3 joint publications

Ishwaria M Subbiah

3 joint publications

Thomas J George